|Table of Contents|

CTNND1 regulates pancreatic cancer cell proliferation,migration and invasion through the Wnt/β-catenin signaling pathway

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 05
Page:
818-825
Research Field:
Publishing date:

Info

Title:
CTNND1 regulates pancreatic cancer cell proliferation,migration and invasion through the Wnt/β-catenin signaling pathway
Author(s):
HUANG Xiaobin123XIE Mengyi4LIU Xingyu2HUANG Xiaodong2LI Jiayu5LAN Chuan1DENG Dawei1ZHANG Guangnian1LI Yong1LI Jianshui1
1.Department of Hepatobiliary Surgery,Affiliated Hospital of North Sichuan Medical College,Sichuan Nanchong 637000,China;2.North Sichuan Medical College,Sichuan Nanchong 637000,China;3.Zigong Hospital of Woman and Children Healthcare,Sichuan Zigong 634000,China;4.Institute of Hepatobiliary Pancreatic Intestine,Affiliated Hospital of North Sichuan Medical College,Sichuan Nanchong 637000,China;5.School of Basic Medicine,Naval Medical University,Shanghai 200433,China.
Keywords:
pancreatic cancerCTNND1Wnt/β-Catenincell migrationtumor invasioncell proliferation
PACS:
R735.9
DOI:
10.3969/j.issn.1672-4992.2024.05.006
Abstract:
Objective:To study the knockdown of CTNND1 through Wnt/ β-Catenin signaling pathway regulates the proliferation,migration and invasion of pancreatic cancer cells,and further provides theoretical basis for molecular targeted therapy in pancreatic cancer.Methods:The expression of CTNND1 in pancreatic cancer and normal tissues was validated through bioinformatics analysis,and further confirmed by immunohistochemistry(IHC) and qPCR.Transwell,wound healing,and cell proliferation assays were conducted to investigate the impact of CTNND1 on the proliferation,migration,and invasion of pancreatic cancer cells.Subcutaneous tumor formation experiments in nude mice were performed to assess the tumorigenic ability of human pancreatic cancer cells with altered CTNND1 expression.Results:Knockdown of CTNND1 in pancreatic cancer cells inhibited the Wnt/β-catenin signaling pathway as well as the proliferation,migration,and invasion capabilities of these cells.Adding of LiCl(a specific activator of Wnt/β-catenin) partially restored the proliferation,migration,and invasion capabilities of CTNND1-knockdown pancreatic cancer cells.Subcutaneous tumor formation in nude mice demonstrated that CTNND1 knockdown suppressed tumor growth.Conclusion:Knockdown of CTNND1 can regulate the proliferation,migration,invasion,and subcutaneous tumor formation ability of pancreatic cancer through the Wnt/β-catenin signaling pathway,both in vitro and in vivo.

References:

[1]SIEGEL RL,MILLER KD,FUCHS HE,et al.Cancer statistics,2021[J].CA:A Cancer Journal for Clinicians,2021,71(1):7-33.
[2] Global Burden of Disease 2019 Cancer Collaboration,KOCARNIK JM,COMPTON K,et al.Cancer incidence,mortality,years of life lost,years lived with disability,and disability-adjusted life years for 29 cancer groups from 2010 to 2019:A systematic analysis for the global burden of disease study 2019[J].JAMA Oncol,2022,8(3):420-444.
[3] WOOD LD,CANTO MI,JAFFEE EM,et al.Pancreatic cancer:Pathogenesis,screening,diagnosis,and treatment[J].Gastroenterology,2022,163(2):386-402.e1.
[4] WU J,CAI J.Dilemma and challenge of immunotherapy for pancreatic cancer[J].Dig Dis Sci,2021,66(2):359-368.
[5] PARK W,CHAWLA A,O' REILLY EM.Pancreatic cancer:A review[J].JAMA,2021,326(9):851-862.
[6] SINGHI AD,KOAY EJ,CHARI ST,et al.Early detection of pancreatic cancer:Opportunities and challenges[J].Gastroenterology,2019,156(7):2024-2040.
[7] HU Y,ZHU S,XU R,et al.Delta-Catenin attenuates medulloblastoma cell invasion by targeting EMT pathway[J].Front Genet,2022,13:867872.
[8] CHEN Z,LEE H J,KIM H,et al.δ-Catenin promotes cell migration and invasion via Bcl-2-regulated suppression of autophagy in prostate cancer cells[J].Am J Cancer Res,2022,12(1):108-122.
[9] VU V,LIGHT T,SULLIVAN B,et al.P120 Catenin potentiates constitutive E-cadherin dimerization at the plasma membrane and regulates trans binding[J].Curr Biol,2021,31(14):3017-3027.e7.
[10] LIU WW,HU J,WANG R,et al.Cytoplasmic p120ctn promotes gefitinib resistance in lung cancer cells by activating PAK1 and ERK pathway[J].Appl Immunohistochem Mol Morphol,2021,29(10):750-758.
[11] LIU D,ZHANG H,CUI M,et al.Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-Catenin pathway and EMT in colorectal cancer[J].Cell Cycle,2020,19(15):1917-1927.
[12] TANG B,TANG F,WANG Z,et al.Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-Catenin signaling[J].J Exp Clin Cancer Res,2016,35(1):82.
[13] MAYERLE J,FRIESS H,BUCHLER MW,et al.Up-regulation,nuclear import,and tumor growth stimulation of the adhesion protein p120 in pancreatic cancer[J].Gastroenterology,2003,124(4):949-960.
[14] LI TH,ZHAO BB,QIN C,et al.IFIT1 modulates the proliferation,migration and invasion of pancreatic cancer cells via Wnt/β-Catenin signaling[J].Cell Oncol,2021,44(6):1425-1437.
[15] LIU F,XIA Z,ZHANG M,et al.SMARCAD1 promotes pancreatic cancer cell growth and metastasis through Wnt/β-Catenin-mediated EMT[J].Int J Biol Sci,2019,15(3):636-646.
[16] LIU M,ZHANG Y,YANG J,et al.Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer[J].Gastroenterology,2021,160(5):1771-1783.
[17] ZHU L,TIAN Q,GAO H,et al.PROX1 promotes breast cancer invasion and metastasis through WNT/β-Catenin pathway via interacting with hnRNPK[J].Int J Biol Sci,2022,18(5):2032-2046.
[18] CAI K,CHEN S,ZHU C,et al.FOXD1 facilitates pancreatic cancer cell proliferation,invasion,and metastasis by regulating GLUT1-mediated aerobic glycolysis[J].Cell Death Dis,2022,13(9):765.
[19] MAO X,XU J,WANG W,et al.Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment:New findings and future perspectives[J].Mol Cancer,2021,20(1):131.
[20] LI J,KANG R,TANG D.Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma[J].Cancer Commun(Lond),2021,41(8):642-660.
[21] SCHACKMANN RCJ,TENHAGEN M,VAN DE VEN RAH,et al.P120-Catenin in cancer-mechanisms,models and opportunities for intervention[J].J Cell Sci,2013,126(Pt 16):3515-3525.
[22] SOTO E,YANAGISAWA M,MARLOW LA,et al.P120 Catenin induces opposing effects on tumor cell growth depending on E-cadherin expression[J].J Cell Biol,2008,183(4):737-749.
[23] THORESON MA,REYNOLDS AB.Altered expression of the Catenin p120 in human cancer:Implications for tumor progression[J].Differentiation,2002,70(9-10):583-589.
[24] TIAN W,YUAN H,QIN S,et al.Kaiso phosphorylation at threonine 606 leads to its accumulation in the cytoplasm,reducing its transcriptional repression of the tumour suppressor CDH1[J].Mol Oncol,2022,16(17):3192-3209.
[25] LOBANOVA Y,FILONOVA G,KAPLUN D,et al.TRIM28 regulates transcriptional activity of methyl-DNA binding protein Kaiso by SUMOylation[J].Biochimie,2023,206:73-80.
[26] DAI SD,WANG Y,ZHANG JY,et al.Upregulation of δ-Catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer[J].Cancer Sci,2011,102(1):95-103.
[27] LESSEY LR,ROBINSON SC,CHAUDHARY R,et al.Adherens junction proteins on the move-from the membrane to the nucleus in intestinal diseases[J].Front Cell Dev Biol,2022,10:998373.
[28] PIERRE CC,HERCULES SM,YATES C,et al.Dancing from bottoms up - roles of the POZ-ZF transcription factor Kaiso in cancer[J].Biochim Biophys Acta Rev Cancer,2019,1871(1):64-74.
[29] JING J,LIU J,WANG Y,et al.The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells[J].Oncol Rep,2019,41(3):1980-1990.
[30] CAI K,DENG L,ZHENG D,et al.MICAL1 facilitates pancreatic cancer proliferation,migration,and invasion by activating WNT/β-Catenin pathway[J].J Transl Med,2022,20(1):528.
[31] CHEN L,XU Z,LI Q,et al.USP28 facilitates pancreatic cancer progression through activation of Wnt/β-Catenin pathway via stabilising FOXM1[J].Cell Death Dis,2021,12(10):887.

Memo

Memo:
2018四川省科学技术局项目(编号:2018JY0489);2019四川省南充市市校科技战略合作专项(编号:19SXHZ0175);2020四川省卫生和计划生育委员会研究项目(编号:20PJ150);2021四川省卫生和计划生育委员会研究项目(编号:21PJ104)
Last Update: 2024-01-30